Press

Press Release 22-03-10

on Monday, 22 March 2010. Posted in Press

Dr. Andrew Weil and the Folks Who Do Not Exist

 Press Release 22-03-10

Dr.Weil is the leading integrative medicine physician in the US. In that role he has used his experience and study to create, for physicians, a course of instruction at the University of Arizona.

One of the herbal medicines studied is cannabis. Cannabis is the plant that representatives of the US government (drug czar, DEA, FDA and others charged with knowing such stuff), say has too little research to be used safely by humans.

If anyone wants to study cannabis one of the major sources of cannabis research and clinical use on humans is the extensive library created by Patients Out of Time and publically displayed at www.MedicalCannabis.com

The researchers and health care professionals who have produced and published this world wide science, including the science itself, do not exist. The federal government repeats that continually and the media apes their propaganda. The DEA and HHS have been studying 50,000 pages of research since October 2002. What they study is at www.drugscience.org.

Just a few days ago Andrea Barthwell, a spokesperson for US “marijuana” policy said on Fox News that the data, and therefore the people who have worked for decades to study and publish cannabis science, simply do not exist.

There are two reasons she and the others so situated expose their total lack of knowledge about which they speak.  Ignorance or hubris. They either know the science exists and just do not say so or they are placed in public to lie.

ctc120The Sixth National Clinical Conference on Cannabis Therapeutics will be held on April 15-17, 2010 in Warwick, RI.  It is accredited by the AMA and ANA. Hundreds of health care professionals will attend and Dr. Weil will speak to them about his work as will other physicians and researchers from Canada, the US, Israel, Jamaica and Brazil.

You would think all those folks who work in the war on people who use drugs could have found out Patients Out of Time exists.  At $17 billion a year the US government is certainly able to find out what we know; that the AMA and ANA know the data exists; that there have been five previous conferences presenting such knowledge.

Missing is credibility, honesty and academic professionalism at the federal level.

That behavior is what should not exist.

Al Byrne, Co-founder, Patients Out of Time

This email address is being protected from spambots. You need JavaScript enabled to view it.

www.MedicalCannabis.com

VMMA Press Release 16-04-10

on Friday, 16 April 2010. Posted in Press, cannabis-patients-network

Veterans for Medical Cannabis Access

VMMA Press Release 16-04-10

Veterans Health Administration Tolerates Veterans Use of Medicinal Cannabis as Adjunct Therapy to VA Hospital Supplied Opioids.

In a July 6, 2010 letter addressed to the Executive Director of Veterans for  Medical Cannabis Access (VMMA), Robert A. Petzel, MD, Under Secretary for Health of the Department of Veterans Affairs wrote, “If a Veteran obtains and uses medical marijuana in a manner consistent with state law, testing positive for marijuana would not preclude the Veteran from receiving opioids for pain management in a Department of Veterans Affairs (VA) facility.”

According to Michael Krawitz, recipient of the letter and himself a disabled US Air Force Veteran, “The work we did on this issue was for all Vets of all time periods.  My personal injuries led me to find medical cannabis to help control my chronic pain. My fellow Vets, thousands of them have found the same medicine to relieve their suffering and will appreciate this strong support and Dr. Petzel's attention.”

The VHA letter went on to clarify that, ”The provider will take the use of medical marijuana into account in all prescribing decisions, just as the provider would for any other medication.”

Pain contracts now in place in the VHA will need to be rewritten. “Standard pain management agreements should draw a clear distinction between the use of illegal drugs, and legal medical marijuana.”

Modern research shows Cannabis to be an important adjunct medicine that both compliments and reduces opioid therapy and is discussed in video lectures at www.medicalcannabis.com, the web site of Patients Out of Time.

Veteran Organizations and Media Contact: Michael “Mike” Krawitz

(540) 365-2141  -  This email address is being protected from spambots. You need JavaScript enabled to view it.

Press Release - CRP Writ 24-05-11

on Tuesday, 24 May 2011. Posted in Press, News

Press Release - CRP Writ 24-05-11

Patients Out of Time joined others in an effort to put the DEA on notice that it must respond to a Petition to Reschedule Cannabis that was submitted in 2002 in accordance with the regulations of the Controlled Substances Act.

On Monday, May 23, 2011 a coalition of advocacy groups and patients filed suit (a Writ of Mandamus) in the DC Circuit Court to force the current administration to answer the 9 year old petition to remove cannabis/marijuana from Schedule I (forbidden category) and place it in a less restrictive category.

Background
The Cannabis Rescheduling Petition is a scientific argument why the federal government must legally recognize the accepted medical use of Cannabis (marijuana) and regulate it in the same fashion as pharmaceutical drugs.
Cannabis/marijuana is regulated by the Controlled Substances Act (CSA) as a Schedule I substance, restricted solely for research purposes. The CSA establishes a process by which the scheduling of a substance can be reconsidered. This rescheduling process requires the filing of a detailed report of scientific evidence and the CSA specifies which aspects of the scientific record are relevant to the scheduling process. The Cannabis Rescheduling Petition seeks to have marijuana rescheduled into one of the four other schedules, all of which allow access for medical use. (full details found at www.DrugScience.org).

ctc120
The Cannabis Rescheduling Petition was submitted to the DEA in October of 2002 by the Coalition to Reschedule Cannabis (CRC)Patients Out of Time along with Americans for Safe Access are two of the primary organizations in the CRC.  In effect, the petition presents evidence to show that cannabis does have accepted medical use in the U.S., it is safe for medical use and it is not highly addictive and therefore does not meet Schedule I criteria.

The Writ of Mandamus
The petition for the Writ of Mandamus (PDF) has been filed in the United States Court of Appeals for the DC Circuit since it is directed at the DEA and the U.S. Attorney General.  The goal is to compel the DEA to finally answer the Cannabis Rescheduling Petition.

"The evidence has only gotten stronger for medicinal cannabis, while the DEA refuses to answer the petition.  There are now 16 states along with Washington DC that have laws that recognized the medical value of cannabis.  Enough is enough.  Patients need this medicine now," states Mary Lynn Mathre, President of Patients Out of Time.


What Next?
The DEA will be forced to issue a formal answer to the Petition.  "We don't know how the DEA will rule on the Cannabis Rescheduling Petition.  Common sense, science, and compassion should lead them to placing it in a Schedule lower than III (which is the category that dronabinol or synthetic THC is now at).  However, past actions by the DEA lead us to believe that they will continue to maintain the reefer madness myths of marijuana and deny legal access to cannabis," predicts Mathre.

If the DEA refuses to move cannabis out of Schedule I, the CRC will formally challenge their decision.  In 1988, the DEA's Administrative Law Judge Francis Young ruled on a previous marijuana rescheduling petition that it should be removed from Schedule I and he stated that, "Marijuana, in its natural form, is one of the safest therapeutically active substances known to man."  The DEA rejected its own judge's ruling.  But much has changed since then.  Scientists have discovered that humans (and other animals) have an endocannabinoid system (ECS) - we have receptors for cannabinoids throughout our bodies and we make our own cannabinoids (similar to those made by the cannabis plant).  This is a very important molecular-based system that helps protect us from stressors and keeps us in balance.  This new science helps us understand how and why cannabis has such a wide safety margin and has such a wide array of indications for use.  "Cannabis can boost the ECS when it is overworked or supplement it if it begins to fail.  It is time to put cannabis back in the pharmacopoeia and allow patients legal access to this herbal medicine," says Mathre.
 
- Mary Lynn Mathre, President, Patients Out of Time
1472 Fish pond Rd., Howardsville, VA 24562
434-262-4484
email - This email address is being protected from spambots. You need JavaScript enabled to view it.

Facebook Community